Exosomal long non-coding RNAs in glioblastoma

Area of Science:

• Neuro-oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults.
• Current diagnostic methods (MRI, biopsy) have limitations in accuracy and invasiveness.
• There is a critical need for minimally invasive, accurate, and cost-effective diagnostic tools for GBM.

Purpose of the Study:

• To review the role of exosomal long non-coding RNAs (lncRNAs) in GBM pathogenesis.
• To explore the potential of exosomal lncRNAs as biomarkers for early GBM diagnosis and prognosis.
• To discuss the clinical applications of exosomal lncRNAs in GBM management.

Main Methods:

• Literature review focusing on exosomal lncRNAs in GBM.
• Analysis of studies investigating the regulatory roles of lncRNAs in GBM development and progression.
• Evaluation of research on exosomal lncRNA specificity and sensitivity for diagnostic potential.

Main Results:

• Exosomal lncRNAs are implicated in GBM immunomodulation, metastasis, development, and drug resistance.
• These lncRNAs regulate genes that promote tumor growth and alter signaling pathways.
• Exosomal lncRNAs exhibit high specificity and sensitivity, making them promising diagnostic indicators.

Conclusions:

• Exosomal lncRNAs are key players in GBM pathogenesis.
• These molecules hold significant potential as non-invasive biomarkers for early GBM diagnosis.
• Further research can translate exosomal lncRNA detection into clinical applications for improved patient outcomes.